Icahn Gets Hedge Backing in Pharm. Attack

Carl Icahn is winning support for his fight against Enzon Pharmaceuticals from a prominent hedge fund investor, according to HedgeFund.net

New Jersey-based hedge fund DellaCamera Capital Management is backing Icahn in his bid to shake up management at Enzon, one of the activist shareholder’s targets since 2008. DellaCamera is also looking for Enzon to fire Goldman Sachs as their financial advisor.

Leave a Reply

• THE D100 BOARDROOM LEADERS FOR 2009
• Enzon, Shareholders Agree to Cease-fire
• Paulo Costa in as Amylin Chair
• Icahn Sued by R2 Investments for Conflict of Interest
• Yahoo-Microsoft Deal Hopes Restored

News Stories

• Rio’s Cloud Peak down in debut
• Black Friday deals might not cut it
• Stocks dip as investors weigh recovery bets
• U.S. economy in Q3 less brisk
• Ex-Vivendi CEO Messier testifies
• Cautious optimism as job losses slow
• Lawmakers urged to drop owner cap
• Home sales at highest since July 2007
• D.R. Horton results miss estimates
• U.S. layoffs fall in October
• JM Smucker beats out Folgers coffee
• Trichet warns banks risk addiction to support
• Goldman Investors want bigger share of profits
• AnnTaylor revenue down, cautious
• GE, Vivendi differ on NBCU valuation
• Dell: corporate spending for recovery
• Ferrero, Hershey likely to break up Cadbury
• Burkle buys Barneys New York debt: report
• Stocks point to lower open
• Sears loss narrows as Kmart improves